Showing results (1771-1780 of 1,823) with videos related to
Sort By:
Pageof 183
Blood Advances|June 15, 2025
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphomaNeha Akkad, Lei Feng, Jason R Westin, et al.The Lancet. Oncology|December 17, 2013
Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trialJason R Westin, Fuliang Chu, Min Zhang, et al.Age and Ageing|June 29, 2023
Pharmacological treatment of neuropsychiatric symptoms of dementia: a network meta-analysisYu-Yuan Huang, Teng Teng, Cinzia D Giovane, et al.Leukemia & Lymphoma|January 24, 2020
Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FLPaolo Strati, Mohamed Amin Ahmed, Loretta J Nastoupil, et al.Cancer|May 4, 2018
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphomaJorge E Romaguera, Michael Wang, Lei Feng, et al.Blood Advances|March 31, 2022
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximabMario L Marques-Piubelli, Edwin R Parra, Lei Feng, et al.Cell Death & Disease|August 14, 2024
GPR50 regulates neuronal development as a mitophagy receptorJi-Chuan Liu, Xiu-Yun Zhao, Ming-Lei Wu, et al.JAMA Ophthalmology|July 7, 2018
Development and Evaluation of Diagnostic Criteria for Vogt-Koyanagi-Harada DiseasePeizeng Yang, Yuanyuan Zhong, Liping Du, et al.Aging|December 3, 2020
Cohort profile: the Diet and Healthy Aging (DaHA) study in SingaporeRongjun Yu, Ye Sun, Kaisy Xinhong Ye, et al.Endoscopic Ultrasound|July 1, 2024
New-onset diabetes is a predictive risk factor for pancreatic lesions in high-risk individuals: An observational cohort studySeyda Baydogan, Chirayu Mohindroo, Merve Hasanov, et al.Pageof 183